L&C Bio Co., Ltd (290650.KQ)

KRW 22450.0

(-1.54%)

Gross Profit Summary of L&C Bio Co., Ltd

L&C Bio Co., Ltd's latest annual gross profit in 2023 was 32.52 Billion KRW , up 20.51% from previous year.
L&C Bio Co., Ltd's latest quarterly gross profit in 2024 Q2 was 8.6 Billion KRW , up 20.82% from previous quarter.
L&C Bio Co., Ltd reported a annual gross profit of 26.99 Billion KRW in annual gross profit 2022, down -5.13% from previous year.
L&C Bio Co., Ltd reported a annual gross profit of 28.45 Billion KRW in annual gross profit 2021, up 45.46% from previous year.
L&C Bio Co., Ltd reported a quarterly gross profit of 8.6 Billion KRW for 2024 Q2, up 20.82% from previous quarter.
L&C Bio Co., Ltd reported a quarterly gross profit of 7.52 Billion KRW for 2023 Q1, up 1.11% from previous quarter.

Annual Gross Profit Chart of L&C Bio Co., Ltd (2023 - 2015)

Historical Annual Gross Profit of L&C Bio Co., Ltd (2023 - 2015)

Year	Gross Profit	Gross Profit Growth
2023	32.52 Billion KRW	20.51%
2022	26.99 Billion KRW	-5.13%
2021	28.45 Billion KRW	45.46%
2020	19.55 Billion KRW	4.79%
2019	18.66 Billion KRW	39.48%
2018	13.38 Billion KRW	20.16%
2017	11.13 Billion KRW	59.33%
2016	6.98 Billion KRW	62.24%
2015	4.3 Billion KRW	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	7.64 Billion KRW	12.92%
2024 Q2	8.6 Billion KRW	20.82%
2023 Q1	7.52 Billion KRW	1.11%
2023 Q4	6.77 Billion KRW	-42.52%
2023 FY	32.52 Billion KRW	20.51%
2023 Q2	8.07 Billion KRW	7.37%
2023 Q3	11.78 Billion KRW	45.96%
2022 Q2	6.51 Billion KRW	0.7%
2022 FY	26.99 Billion KRW	-5.13%
2022 Q4	7.43 Billion KRW	13.27%
2022 Q3	6.56 Billion KRW	0.77%
2022 Q1	6.47 Billion KRW	-24.57%
2021 Q2	6.47 Billion KRW	5.89%
2021 Q3	7.28 Billion KRW	12.5%
2021 Q4	8.57 Billion KRW	17.79%
2021 FY	28.45 Billion KRW	45.46%
2021 Q1	6.11 Billion KRW	10.73%
2020 Q3	4.96 Billion KRW	3.33%
2020 Q4	5.52 Billion KRW	11.19%
2020 FY	19.55 Billion KRW	4.79%
2020 Q1	4.22 Billion KRW	-18.31%
2020 Q2	4.8 Billion KRW	13.71%
2019 Q4	5.17 Billion KRW	17.25%
2019 FY	18.66 Billion KRW	39.48%
2019 Q3	4.41 Billion KRW	-11.59%
2019 Q2	4.99 Billion KRW	22.14%
2019 Q1	4.08 Billion KRW	10.13%
2018 Q2	3.56 Billion KRW	11.5%
2018 Q1	3.19 Billion KRW	0.0%
2018 Q3	2.91 Billion KRW	-18.35%
2018 Q4	3.71 Billion KRW	27.51%
2018 FY	13.38 Billion KRW	20.16%
2017 FY	11.13 Billion KRW	59.33%
2016 FY	6.98 Billion KRW	62.24%
2015 FY	4.3 Billion KRW	0.0%

Peer Gross Profit Comparison of L&C Bio Co., Ltd

Name	Gross Profit	Gross Profit Difference
Osang Healthcare Co.,Ltd	219.75 Billion KRW	85.199%
InBody Co.,Ltd	128.11 Billion KRW	74.611%
Curexo Inc.	17.95 Billion KRW	-81.147%
Seegene, Inc.	180.07 Billion KRW	81.936%
i-SENS, Inc.	101.04 Billion KRW	67.808%
Ray Co., Ltd.	65.08 Billion KRW	50.026%
Gencurix Inc.	422.03 Million KRW	-7607.296%
Sugentech Inc.	-5.88 Billion KRW	653.105%